Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 155.17 USD -0.21% Market Closed
Market Cap: 373.6B USD
Have any thoughts about
Johnson & Johnson?
Write Note

Intrinsic Value

The intrinsic value of one JNJ stock under the Base Case scenario is 159.64 USD. Compared to the current market price of 155.17 USD, Johnson & Johnson is Undervalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

JNJ Intrinsic Value
159.64 USD
Undervaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Johnson & Johnson

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for JNJ cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about JNJ?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Johnson & Johnson

Provide an overview of the primary business activities
of Johnson & Johnson.

What unique competitive advantages
does Johnson & Johnson hold over its rivals?

What risks and challenges
does Johnson & Johnson face in the near future?

Has there been any significant insider trading activity
in Johnson & Johnson recently?

Summarize the latest earnings call
of Johnson & Johnson.

What significant events have occurred
in Johnson & Johnson over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Johnson & Johnson.

Provide P/S
for Johnson & Johnson.

Provide P/E
for Johnson & Johnson.

Provide P/OCF
for Johnson & Johnson.

Provide P/FCFE
for Johnson & Johnson.

Provide P/B
for Johnson & Johnson.

Provide EV/S
for Johnson & Johnson.

Provide EV/GP
for Johnson & Johnson.

Provide EV/EBITDA
for Johnson & Johnson.

Provide EV/EBIT
for Johnson & Johnson.

Provide EV/OCF
for Johnson & Johnson.

Provide EV/FCFF
for Johnson & Johnson.

Provide EV/IC
for Johnson & Johnson.

Show me price targets
for Johnson & Johnson made by professional analysts.

What are the Revenue projections
for Johnson & Johnson?

How accurate were the past Revenue estimates
for Johnson & Johnson?

What are the Net Income projections
for Johnson & Johnson?

How accurate were the past Net Income estimates
for Johnson & Johnson?

What are the EPS projections
for Johnson & Johnson?

How accurate were the past EPS estimates
for Johnson & Johnson?

What are the EBIT projections
for Johnson & Johnson?

How accurate were the past EBIT estimates
for Johnson & Johnson?

Compare the revenue forecasts
for Johnson & Johnson with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Johnson & Johnson and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Johnson & Johnson against its competitors.

Analyze the profit margins
(gross, operating, and net) of Johnson & Johnson compared to its peers.

Compare the P/E ratios
of Johnson & Johnson against its peers.

Discuss the investment returns and shareholder value creation
comparing Johnson & Johnson with its peers.

Analyze the financial leverage
of Johnson & Johnson compared to its main competitors.

Show all profitability ratios
for Johnson & Johnson.

Provide ROE
for Johnson & Johnson.

Provide ROA
for Johnson & Johnson.

Provide ROIC
for Johnson & Johnson.

Provide ROCE
for Johnson & Johnson.

Provide Gross Margin
for Johnson & Johnson.

Provide Operating Margin
for Johnson & Johnson.

Provide Net Margin
for Johnson & Johnson.

Provide FCF Margin
for Johnson & Johnson.

Show all solvency ratios
for Johnson & Johnson.

Provide D/E Ratio
for Johnson & Johnson.

Provide D/A Ratio
for Johnson & Johnson.

Provide Interest Coverage Ratio
for Johnson & Johnson.

Provide Altman Z-Score Ratio
for Johnson & Johnson.

Provide Quick Ratio
for Johnson & Johnson.

Provide Current Ratio
for Johnson & Johnson.

Provide Cash Ratio
for Johnson & Johnson.

What is the historical Revenue growth
over the last 5 years for Johnson & Johnson?

What is the historical Net Income growth
over the last 5 years for Johnson & Johnson?

What is the current Free Cash Flow
of Johnson & Johnson?

Discuss the annual earnings per share (EPS)
trend over the past five years for Johnson & Johnson.

Business Breakdown

Johnson & Johnson, often referred to as J&J, is a global healthcare giant that operates in three main segments: Pharmaceuticals, Medical Devices, and Consumer Health Products. Founded in 1886, the company has built a strong reputation for its innovative products, which range from life-saving prescription medications to everyday consumer items such as Band-Aids and Tylenol. With a commitment to improving health and well-being, J&J has consistently invested in research and development, yielding a robust pipeline of drugs and technologies that address critical health challenges, including oncology, immunology, and infectious diseases. This ongoing innovation positions the company favorably in a...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Johnson & Johnson

Current Assets 53.2B
Cash & Short-Term Investments 20.3B
Receivables 16.2B
Other Current Assets 16.8B
Non-Current Assets 125B
Long-Term Investments 505m
PP&E 20.5B
Intangibles 84.3B
Other Non-Current Assets 19.8B
Current Liabilities 51.8B
Accounts Payable 9B
Accrued Liabilities 33.5B
Short-Term Debt 2B
Other Current Liabilities 7.3B
Non-Current Liabilities 56.4B
Long-Term Debt 31.3B
Other Non-Current Liabilities 25.1B
Efficiency

Earnings Waterfall
Johnson & Johnson

Revenue
87.7B USD
Cost of Revenue
-27B USD
Gross Profit
60.7B USD
Operating Expenses
-36.5B USD
Operating Income
24.2B USD
Other Expenses
-9.5B USD
Net Income
14.7B USD

Free Cash Flow Analysis
Johnson & Johnson

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, Johnson & Johnson achieved worldwide sales of $22.5 billion, up 6.3% year-over-year. The Innovative Medicine segment led with $14.6 billion in sales, driven by strong performances from key brands like DARZALEX, which grew by 22.9%. Adjusted operational earnings per share (EPS) guidance was raised to $9.91, primarily due to anticipated sales growth of 5.7% to 6.2%. The company plans significant investments to enhance its pipeline, with a focus on innovative products, despite facing headwinds from the talc litigation. The MedTech sector expects operational sales growth around 5%, reflecting a robust operational strategy.

What is Earnings Call?
Fundamental Scores

JNJ Profitability Score
Profitability Due Diligence

Johnson & Johnson's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Operating Income
66/100
Profitability
Score

Johnson & Johnson's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

JNJ Solvency Score
Solvency Due Diligence

Johnson & Johnson's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Positive Net Debt
62/100
Solvency
Score

Johnson & Johnson's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JNJ Price Targets Summary
Johnson & Johnson

Wall Street analysts forecast JNJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JNJ is 179.79 USD with a low forecast of 156.55 USD and a high forecast of 225.75 USD.

Lowest
Price Target
156.55 USD
1% Upside
Average
Price Target
179.79 USD
16% Upside
Highest
Price Target
225.75 USD
45% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for JNJ?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Nov 24, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for JNJ is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

JNJ Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

JNJ News

Other Videos

Profile

Johnson & Johnson Logo
Johnson & Johnson

Country

United States of America

Industry

Pharmaceuticals

Market Cap

373.5B USD

Dividend Yield

3.13%

Description

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in New Brunswick, New Jersey and currently employs 141,700 full-time employees. The firm operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Contact

NEW JERSEY
New Brunswick
One Johnson & Johnson Plaza
+17325242455.0
www.jnj.com

IPO

1944-09-25

Employees

141 700

Officers

CEO & Chairman
Mr. Joaquin Duato
Executive VP & CFO
Mr. Joseph J. Wolk CPA
Executive VP & Chief Human Resources Officer
Dr. Peter M. Fasolo Ph.D.
Executive VP & Worldwide Chairman of Innovative Medicine
Ms. Jennifer L. Taubert
Executive Vice President of Innovative Medicine, R&D
Dr. John C. Reed M.D., Ph.D.
Controller & Chief Accounting Officer
Mr. Robert J. Decker Jr.
Show More
Executive VP & Chief Information Officer
Mr. James Swanson
Vice President of Investor Relations
Ms. Jessica Moore
Chief Compliance Officer
Mr. Dirk Brinckman
Executive VP & Chief Legal Officer
Ms. Elizabeth Forminard
Show Less

See Also

Discover More
What is the Intrinsic Value of one JNJ stock?

The intrinsic value of one JNJ stock under the Base Case scenario is 159.64 USD.

Is JNJ stock undervalued or overvalued?

Compared to the current market price of 155.17 USD, Johnson & Johnson is Undervalued by 3%.

Back to Top